Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.835 USD | -2.24% | -32.94% | -41.40% |
May. 15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
May. 14 | Top Midday Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.40% | 143M | |
+11.74% | 228B | |
+14.24% | 196B | |
+17.64% | 141B | |
+28.55% | 110B | |
+0.53% | 65.88B | |
+16.66% | 54.3B | |
+6.33% | 52.39B | |
+11.05% | 45.22B | |
+5.10% | 37.12B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Earnings Flash (AKYA) AKOYA BIOSCIENCES Posts Q2 Revenue $23.5M, vs. Street Est of $22.4M